Workflow
保健饮品
icon
Search documents
康养不再是中老年人专属,年轻人已成为消费主力军
Sou Hu Cai Jing· 2025-06-16 12:01
年轻人何以成为健康消费的生力军?充满商机的健康消费市场呈现哪些新看点、新活力? 来源:人民日报数字传播 编辑:棂星 封面来源:pixabay "一边熬夜内卷,一边养生保健",如今,这样自嘲的年轻人,把健康消费当作新"刚需"。 商场超市内,保健品、富含微量元素的食品持续热销;电商平台上,能量补给类、"轻养生"类零食备受追捧;中式养生馆,艾灸、拔罐、按摩等"国潮养 生"预约火爆;户外空间里,骑行、越野、冰雪运动等吸引众多年轻人投身其中,砸下"真金白银"……如今,青年群体日益成为健康消费的生力军,打开 了个性化、品质化的商业新空间,带来新的消费增长点。 康养受追捧 饮料火锅沐浴露 融入养生新理念 曾经,"康养"一词基本专属于中老年人。如今,青年群体也不遑多让,争相加入"养生局"。 青年群体更加关注自身健康、对康养产品需求旺盛,也给生产厂家提供了广阔市场机遇。他们纷纷"各显神通",源源不断地创造优质供给。 近来,有缓解疲劳、改善睡眠等功能的保健食品在年轻人当中引发关注。"健康消费,也需要新概念。我们把中药材制成保健饮品,很受年轻消费者欢 迎。"北京嘉桦生物技术有限公司董事长张学刚说。 相关市场调研显示,与上一代消费者 ...
首个中美欧都认证的机器人出现,A股谁受益?| 0603 张博划重点
Hu Xiu· 2025-06-03 14:24
Group 1 - The market experienced a rebound on June 3, with major indices showing slight increases, and the total trading volume in Shanghai and Shenzhen reaching 1.14 trillion, an increase of 22.3 billion compared to the previous trading day [1] - The focus of the market was on the pharmaceutical and consumer sectors, with over 3,300 stocks rising, leading to the Shanghai Composite Index increasing by 0.43%, the Shenzhen Component Index by 0.16%, and the ChiNext Index by 0.48% [1] - The drone concept gained traction following Ukraine's significant drone attack on Russian airbases, with companies like Yongyue Technology and Zhongtian Rocket achieving consecutive gains [1] Group 2 - BioNTech announced a licensing agreement with Bristol-Myers Squibb for its new cancer drug BNT327, which could yield up to 11.1 billion in milestone payments, highlighting the ongoing trend of large-scale business development agreements in the innovative drug sector [2] - The consumer market saw a resurgence during the Dragon Boat Festival, with new consumption trends emerging, particularly in the 618 shopping event, where companies like Pop Mart, Laopu Gold, and Mixue Group reached new historical highs [2] - The health beverage sector also saw significant activity, with companies like Yinyuan Health achieving a full limit-up, and others like Ruoyuchen, Wancheng Group, and Caibai Co. hitting historical highs [2]
A股午评:创业板指半日跌近1% 新消费概念逆市走强
news flash· 2025-05-27 03:34
Market Overview - The three major A-share indices collectively declined in the morning session, with the Shanghai Composite Index down 0.33%, the Shenzhen Component Index down 0.87%, and the ChiNext Index down 0.98% [1] - The total market turnover for the half-day was 626 billion yuan, a decrease of 34.9 billion yuan compared to the previous day [1] - A total of 3,500 stocks in the market were in the red [1] Sector Performance - Beverage manufacturing, cultivated diamonds, and IP economy sectors led the gains, while the innovative drug sector experienced the largest declines [2] - New consumption concepts showed strong performance, with health drinks, leisure foods, jewelry, and IP economy sectors performing well, leading to multiple stocks hitting the daily limit up [2] - Notable stocks that reached the daily limit up included Chuangyuan Co., Keta Bio, Youyou Foods, and Mingpai Jewelry [2] Hot Stocks and Trends - The top-performing stocks included Huide Technology with five consecutive limit ups, and Zhongchao Holdings and Shangwei Co. with four consecutive limit ups [5] - The strongest sectors included e-commerce, cross-border e-commerce, and western development, with multiple stocks hitting limit up in these categories [7][8][9] - The new consumption sector has been gaining attention, with stocks like Yujing Health and Kuaijishan performing strongly [10] Autonomous Driving Sector - The autonomous logistics vehicle concept was active, with stocks like Kexin Intelligent, Yunnei Power, and Tongda Electric hitting limit up [11] - Several autonomous driving companies have completed new rounds of financing, indicating growth in the sector [11] Innovative Drug Sector - The innovative drug sector is gaining traction, with companies like Huawen Pharmaceutical and Sanofi Guojian showing strong performance [13] - A report from CITIC Securities highlighted that Chinese pharmaceutical companies are rapidly advancing in innovative research and development [13]
天士力闪耀2025乌镇健康大会 共筑OTC市场增长新引擎
Group 1: Event Overview - The 2025 Wuzhen Health Conference and the 4th OTC Conference opened on April 9, showcasing the health industry with various forums and discussions on policies, trends, and dynamics [1] - The event featured multiple segments including the 4th OTC Conference, Traditional Chinese Medicine Anti-Aging Conference, and Digital Health Industry Conference, promoting diverse exchanges and sharing [1] Group 2: Company Showcase - Tianshili set up an independent exhibition booth, creatively designed to blend modern technology with traditional Chinese medicine culture, showcasing its star products in cardiovascular, oncology, digestive metabolism, and neuroscience [3] - The innovative health product display area featured health drinks and nutritional supplements tailored for different age groups, attracting health-conscious consumers [5] Group 3: Thematic Meetings - Tianshili held a special presentation titled "Project Upgrade + Category Innovation to Build a New Engine for OTC Market Growth," emphasizing its commitment to OTC market development and innovation [6] - The presentation included insights on the impact of policy on the nutritional supplement market and Tianshili's innovative growth paths, with attendees actively engaging and taking notes [6][7] Group 4: Networking and Collaboration - The "Tianshili Night" event provided a relaxed atmosphere for business discussions, allowing clients to share market feedback and needs while Tianshili's staff listened and responded [8] - The company aims to foster collaboration and mutual understanding, laying a solid foundation for future partnerships [8] Group 5: Industry Significance - Tianshili's performance at the Wuzhen Health Conference is significant amid challenges like strict regulations and intensified market competition, showcasing its innovative approaches in product development and marketing [10] - The company is committed to collaboration and shared market opportunities, driving continuous growth in the OTC market [10]